Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Legend Biotech Corp (LEGN US)
Watchlist
103
Analysis
Health Care
•
China
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Legend Biotech Corp
•
13 Nov 2024 08:55
Legend Biotech (LEGN.US) Offer Update - Will Deconsolidation Increase the Chances of a Merger ?
The deconsolidation of Legend Bio may not necessarily be directly related to a potential merger, but divisions among major shareholders/co-founders...
Xinyao (Criss) Wang
Follow
243 Views
Share
bullish
•
Legend Biotech Corp
•
15 Oct 2024 08:55
Legend Biotech (LEGN.US) Offer Update - Is the Deal Really Dead?
Given the geopolitical risks, this acquisition is worth considering for both Legend Bio and Genscript. However, the main obstacles are disagreement...
Xinyao (Criss) Wang
Follow
484 Views
Share
bullish
•
Legend Biotech Corp
•
03 Sep 2024 08:55
Legend Biotech (LEGN.US) Offer Update - The Takeover Negotiations Could Reach an Impasse?
Rumors swirl around acquisition price disagreement between Legend Bio and Genscrip. Deal has 50-50 chance of success. Investors still benefit if...
Xinyao (Criss) Wang
Follow
736 Views
Share
bullish
•
Legend Biotech Corp
•
22 Aug 2024 15:00
Legend Biotech: Achieving Regulatory Milestones and Market Approval! - Major Drivers
Legend Biotech, during their second quarter 2024 earnings call, presented a detailed insight into its operations, financial health, and the...
Baptista Research
Follow
185 Views
Share
bullish
•
Legend Biotech Corp
•
01 Aug 2024 08:55
Legend Biotech (LEGN.US) Offer Update - Some New Information About the Takeover Worth the Attention
The potential takeover seems reliable.Genscript will be a big winner but it's uncertain whether Genscript will offer dividends to small/medium...
Xinyao (Criss) Wang
Follow
555 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x